5 results  1 of 1 

1 Efficacy and Safety of Melphalan, Cyclophosphamide and Dexamethasone (MCD) as a Salvage Treatment for Patients with Relapsed/Refractory Multiple Myeloma
Seung-Shin Lee, Je-Jung Lee
Chonnam Med J.2019;55(1):25-30.   Published online 2019 January 25     DOI: http://dx.doi.org/10.4068/cmj.2019.55.1.25
      
2 Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
Ja Min Byun, Jayoun Lee, Sang-Jin Shin, Minjoo Kang, Sung-Soo Yoon, Youngil Koh
Blood Res.2018;53(2):105-109.   Published online 2018 June 25     DOI: http://dx.doi.org/10.5045/br.2018.53.2.105
      
3 Clinical Remission of Renal Amyloidosis after Autologous Peripheral Blood Stem Cell Transplantation
Seong Yeong An, Yon Hee Kim, Young Eun Kwon, Yung Ly Kim, Ki Heon Nam, Heun Choi, Young Ju Kim, Kyoung Sook Park, Hyeon Joo Jeong, Hyung Jung Oh, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Ewha Med J.2013;36(Suppl):S25-S29.   Published online 2013 December 23     DOI: http://dx.doi.org/10.12771/emj.2013.36.S.S25
      
4 Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
Se Ryeon Lee, Seok Jin Kim, Yong Park, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim
Korean J Hematol.2010;45(3):183-187.   Published online 2010 September 30     DOI: http://dx.doi.org/10.5045/kjh.2010.45.3.183
      
5 Pharmacokinetics of High-dose Intravenous Melphalan in Patients Undergoing Autologous Stem Cell Transplantation
So Young Lee, Jung A Kim, Jung Won Lee, Hyo Jung Koo, Hoon-Kyo Kim
Korean J Hematol.2007;42(2):122-128.   Published online 2007 June 19     DOI: http://dx.doi.org/10.5045/kjh.2007.42.2.122
   

 1 of 1